LMLLFPHARMADRUG INC.

About PHARMADRUG INC. (LMLLF)

PHARMADRUG INC. (LMLLF) is a Drug Manufacturers - Specialty & Generic company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs. PharmaDrug owns 100% of Sairiyo Therapeutics ("Sairiyo"), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious disease (including Covid-19) and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions.

Products and services

Pharmadrug does not have any products or services at this time

LMLLF key facts

Ticker symbol

LMLLF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Employees

1

Estimated market cap

$946.7K (as of Apr 10, 2025)

Shares outstanding

108,197,219

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Interim Financial Report (Jun 30, 2023)

PHARMADRUG INC. leadership

• Robert J. Steen — CEO
• Keith Li — CFO
• Paul Van Slyke — CSO
• Kookie Miller — Company Secretary

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with L